A research team revealed that insulin-like growth factor-binding protein 6 (IGFBP6) serves as a potential therapeutic target ...

In atherosclerosis, the vascular smooth muscle cell (VSMC) contributes to vessel wall inflammation and lipoprotein retention, as well as to the formation of the fibrous cap that provides stability ...

Two conditions within this category are atherosclerosis and arteriosclerosis, which are often confused. Both conditions involve changes in the arterial walls. However, arteriosclerosis is the ...

The following is a summary of “Contribution of type 2 diabetes to major adverse cardiovascular events (MACE) in a long-term observational study with different stages of atherosclerosis,” published in ...

The same mechanisms involved in COVID-related cardiovascular events are responsible for COVID-related myocarditis.

A number of different strategies can be developed to protect people against atherosclerosis or to treat patients with clinical symptoms thereof. In our opinion, DNA and protein vaccination in ...

Researchers from Fundación Jiménez Díaz and affiliated organizations have published data from a study that aimed to identify ...

A common genetic pathway may account for increased risk for atherosclerotic disease in patients with chronic widespread musculoskeletal pain.

A research team led by Prof. WENG Jianping from the University of Science and Technology of China (USTC) of the Chinese ...

Atherosclerosis is a chronic, systemic, inflammatory and metabolic disease and pathologic process characterized by the accumulation of cholesterol and calcium plaque within the arterial wall.

The factors underlying accelerated atherosclerosis in diabetes extend beyond dyslipidemia, hypertension and obesity. Even after correction of these typical risk factors, patients with diabetes ...

The following is a summary of “Relationship between left ventricular shape and cardiovascular risk factors: comparison ...